A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/2002
12/27/2002	CA2451874A1 Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells
12/27/2002	CA2450936A1 Purine inhibitors of phosphodiesterase (pde) 7
12/27/2002	CA2450934A1 Pyrimidine inhibitors of phosphodiesterase (pde) 7
12/27/2002	CA2450724A1 Quinazoline and pyrido¬2,3-d\|pyrimidine inhibitors of phosphodiesterase (pde) 7
12/27/2002	CA2450659A1 Tryptase inhibitors
12/27/2002	CA2450245A1 4-piperazinylindole derivatives with 5-ht6 receptor affinity
12/27/2002	CA2450067A1 Proteins associated with cell growth, differentiation, and death
12/27/2002	CA2449916A1 Imidazole derivatives for modulating sodium channels
12/27/2002	CA2449754A1 Immune response modifiers for the treatment of periodontal disease
12/27/2002	CA2448506A1 Dna molecules and recombinant dna molecules for producing humanized monoclonal antibodies to s. mutans
12/27/2002	CA2448298A1 Phenylpyridine carbonyl piperazine derivative
12/27/2002	CA2446285A1 Fibroblast growth factor and nucleic acid encoding same
12/27/2002	CA2443466A1 An aqueous pharmaceutical preparation of cilostazol for parenteral use
12/27/2002	CA2430627A1 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
12/26/2002	US20020198367 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof
12/26/2002	US20020198262 Alanine-and glycine-containing therapeutic agent for hepatitis
12/26/2002	US20020198261 Liquid pharmaceutical compositions
12/26/2002	US20020198259 Treatment of disease caused by procedural vascular trauma and/or an increased level of plasma homocysteine
12/26/2002	US20020198251 Substituted 2-dialkylaminoalkylbiphenyl derivatives
12/26/2002	US20020198248 Therapeutic methods and compositions involving isoflavones
12/26/2002	US20020198239 Oxidizing 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl)thio)-1H -benzimidazole into S-omeprazole in an organic solvent, convering formed S-omeprazole into corresponding potassium salt by treating with potassium source
12/26/2002	US20020198236 Small organic molecule regulators of cell proliferation
12/26/2002	US20020198214 Such as (3-(4-(4-fluoro-benzyl)-piperidine-1-carbonyl)-4-methoxy-phenyl)-oxo-acetic acid methyl ester for proinflammation response in multiple sclerosis, inflammatory bowel disease, osteoarthritis, and other arthritic conditions
12/26/2002	US20020198213 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
12/26/2002	US20020198198 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
12/26/2002	US20020198197 Metabotropic glutamate receptor agonist for treatment or prevention of acute and/or chronic neurological disorders
12/26/2002	US20020198175 Administering a selected modified or unmodified resistant starch or mixtures thereof; amylose starch obtained from maize, barley, and legumes, bananas, potatoes, rice or wheat starch
12/26/2002	US20020198170 Formulations of adenosine a1 agonists
12/26/2002	US20020198143 B7-like polynucleotides, polypeptides, and antibodies
12/26/2002	US20020197666 Human chordin-related proteins and polynucleotides encoding them
12/26/2002	US20020197654 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof
12/26/2002	US20020197609 Method of determining a chemotherapeutic regimen based on glutathione-S-transferase pi expression
12/26/2002	US20020197275 Process for improving glucose metabolism, satiety, and nutrient absorption in companion animals
12/26/2002	US20020197259 Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers
12/26/2002	US20020197253 Compositions and methods for promoting or inhibiting NDPK
12/26/2002	US20020197235 Method for short-term and long-term drug dosimetry
12/26/2002	US20020197208 Low density radionuclide-containing particulate material
12/26/2002	US20020197207 Radionuclide-coated particulate material
12/26/2002	CA2391574A1 Cosmetic or dermatological composition including an association between an elastase-inhibiting compound of the n-acylamino amides family and at least one muscle relaxant agent
12/25/2002	CN1387531A Pyrazolo [4,3-d] pyrimidine derivs.
12/25/2002	CN1387530A Imidazopyridine derivs. used as phosphodiesterase VII inhibitors
12/25/2002	CN1387514A Aromatic sulfone hydroxamic acid metalloprotease inhibitor
12/25/2002	CN1387513A Positive modulators of nicotinic receptor agonists
12/25/2002	CN1387512A Positive modulators for nicotinic receptor agonists
12/25/2002	CN1387444A Method of treatment using anti-ErbB antibody-maytansinoid conjugates
12/25/2002	CN1387430A Liver selective therapy
12/25/2002	CN1386744A Process for extracting triterpenic acid from gleditschia, and medical use and Chinese medicine of triterpenic acid
12/25/2002	CN1386545A Antrodia camphorata preparation for protecting liver
12/25/2002	CN1386529A Medicine 'Shendantongling Keshi Dan' for treating renal calculus and biliary calculus
12/25/2002	CN1386523A Instant particles for treating biliary calculus
12/25/2002	CN1386444A Oral liquid of acanthopanax bark
12/25/2002	CN1097053C 1,2,3,4-tetrahydro-benzofuro [3,2-c] pyridine derivs., preparing method and use thereof
12/25/2002	CN1097051C N-heteroaryl-pyridinesulfonamide derivs. and their use as endotheliin antagonists
12/25/2002	CN1096867C Antiulcer agent and adhesion inhibitor for helicobacter pyroli
12/24/2002	US6498274 Amide derivatives for the treatment of diseases mediated by cytokines
12/24/2002	US6498178 Inhibitors of IMPDH enzyme
12/24/2002	US6498177 Alpha 2 adrenergic receptor agonist; analgesic, sedative and anaesthetic agents
12/24/2002	US6498171 Hydroxyomeprazole compositions
12/24/2002	US6498165 Pyrimidine compounds; prophylaxis and treatment of such as immune diseases, hyperproliferative disorders, cancer, angiogensis, atheroscelerosis, graft rejection, rheumatoid arthritis, psoriasis
12/24/2002	US6498162 Treating inflammatory and allergic diseases of respiratory tract and diseases of central nervous system
12/24/2002	US6498151 Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors
12/24/2002	US6497906 Anticholesterol, reduced menstrual bleeding
12/24/2002	US6497859 Cooling agents, pharmaceutical compositions having cooling agents and processes for making and using same
12/24/2002	CA2271302C Dentifrice compositions containing polyphosphate and fluoride
12/23/2002	WO2002094290A1 Use of lps for treating intestinal inflammation processes
12/23/2002	CA2414288A1 Use of lps in the treatment of intestinal inflammatory processes
12/21/2002	CA2390966A1 Compound for the treatment of atherosclerotic-thrombotic pathological conditions
12/19/2002	WO2002101069A2 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
12/19/2002	WO2002101048A2 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
12/19/2002	WO2002101008A2 Intracellular signaling molecules
12/19/2002	WO2002100899A2 Medicament for treating tumours and their metastases using a binding molecule against bone-sialoprotein
12/19/2002	WO2002100888A1 Somatostatin-dopamine chimeric analogs
12/19/2002	WO2002100863A1 Corticotropin releasing factor antagonists
12/19/2002	WO2002100859A1 Pde iv inhibitors
12/19/2002	WO2002100857A1 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease
12/19/2002	WO2002100854A1 Lactone formulations and method of use
12/19/2002	WO2002100851A2 Thiophene derivatives as antiviral agents for flavivirus infection
12/19/2002	WO2002100849A2 Novel nitriles useful as reversible inhibitors of cysteine proteases
12/19/2002	WO2002100846A1 Compounds and methods for the treatment or prevention of flavivirus infections
12/19/2002	WO2002100838A1 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators
12/19/2002	WO2002100826A2 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
12/19/2002	WO2002100823A1 New compounds useful in reflux disease
12/19/2002	WO2002100813A2 Modulators of peroxisome proliferator activated receptors
12/19/2002	WO2002100812A1 Carboxylic acid derivative and salt thereof
12/19/2002	WO2002100486A1 Method and apparatus for treating uterine myoma
12/19/2002	WO2002100429A1 Combination therapies using vitamin b12 and interferon for treatment of viral, proliferative and inflammatory diseases
12/19/2002	WO2002100428A1 Combination therapies using vitamin b12 and therapeutic agents for treatment of viral, proliferative and inflammatory diseases
12/19/2002	WO2002100427A1 Liver generation promoter
12/19/2002	WO2002100416A1 Socs-5 molecules, screening therefore and therapeutic uses thereof
12/19/2002	WO2002100415A2 4'-substituted nucleosides for the treatment of diseases mediated by the hepatitis c virus
12/19/2002	WO2002100405A1 Isoquinoline inhibitors of p38
12/19/2002	WO2002100402A1 Compositions comprising nitrofurantoin and uva ursi
12/19/2002	WO2002100400A1 Organic nitrate-based compounds for the treatment of vasculopathies
12/19/2002	WO2002100392A1 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity
12/19/2002	WO2002100386A1 Controlled heat induced rapid delivery of pharmaceuticals from skin depot
12/19/2002	WO2002100354A2 Pyrrolo[2,3-d]pyrimidine nucleoside analogs
12/19/2002	WO2002100347A2 Prodrugs of gaba analogs, compositions and uses thereof
12/19/2002	WO2002100344A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
12/19/2002	WO2002100341A2 Compounds for the treatment of metabolic disorders
12/19/2002	WO2002100336A2 Tissue-specific endothelial membrane proteins

1 ... 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 ... 1258